Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering
NEW YORK — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the pricing of an underwritten public off
(Financial Post, 2025-10-30T02:16:29Z)